Food and Drug Administration, HHS.
The Food and Drug Administration (FDA) is publishing a list of premarket approval applications (PMAs) that have been approved. This list is intended to inform the public of the availability of safety and effectiveness summaries of approved PMAs through the Internet and the agency's Division of Dockets Management.
Submit written requests for copies of summaries of safety and effectiveness data to the Division of Dockets Management (HFA-305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852. Please cite the appropriate docket number as listed in Table 1 of this document when submitting a written request. See the SUPPLEMENTARY INFORMATION section for electronic access to the summaries of safety and effectiveness.Start Further Info
FOR FURTHER INFORMATION CONTACT:
Samie Allen, Center for Devices and Radiological Health (HFZ-402), Food and Drug Administration, 9200 Corporate Blvd., Rockville, MD 20850, 240-276-4013.End Further Info End Preamble Start Supplemental Information
In the Federal Register of January 30, 1998 (63 FR 4571), FDA published a final rule that revised 21 CFR 814.44(d) and 814.45(d) to discontinue individual publication of PMA approvals and denials in the Federal Register. Instead, the agency now posts this information on the Internet on FDA's home page at http://www.fda.gov. FDA believes that Start Printed Page 52381this procedure expedites public notification of these actions because announcements can be placed on the Internet more quickly than they can be published in the Federal Register, and FDA believes that the Internet is accessible to more people than the Federal Register.
In accordance with section 515(d)(4) and (e)(2) of the Federal Food, Drug, and Cosmetic Act (the act) (21 U.S.C. 360e(d)(4) and (e)(2)), notification of an order approving, denying, or withdrawing approval of a PMA will continue to include a notice of opportunity to request review of the order under section 515(g) of the act. The 30 day period for requesting reconsideration of an FDA action under § 10.33(b) (21 CFR 10.33(b)) for notices announcing approval of a PMA begins on the day the notice is placed on the Internet. Section 10.33(b) provides that FDA may, for good cause, extend this 30 day period. Reconsideration of a denial or withdrawal of approval of a PMA may be sought only by the applicant; in these cases, the 30 day period will begin when the applicant is notified by FDA in writing of its decision.
The regulations provide that FDA publish a quarterly list of available safety and effectiveness summaries of PMA approvals and denials that were announced during that quarter. The following is a list of approved PMAs for which summaries of safety and effectiveness were placed on the Internet from April 1, 2007, through June 30, 2007. There were no denial actions during this period. The list provides the manufacturer's name, the product's generic name or the trade name, and the approval date.
|PMA No./Docket No.||Applicant||TRADE NAME||Approval Date|
|P050049/2007M-0174||Abbott Laboratories||ABBOTT AXSYM HBSAG ASSAY||June 1, 2006|
|P040048/2007M-0259||Zimmer, Inc.||TRILOGY AB ACETBULAR SYSTEM||June 28, 2006|
|P060003/2007M-0161||Abbott Laboratories||AXSYM AUSAB REAGENT PACK, STANDARD CALIBRATORS, CONTROLS||August 7, 2006|
|P060009/2007M-0160||Abbott Laboratories||AXSYM CORE-M 2.0 & 2.0 CONTROLS||August 25, 2006|
|P050048/2007M-0151||Bio-Rad Laboratories, Inc.||MONOLISA ANTI-HBS EIA||August 25, 2006|
|P060007/2007M-0152||Abbott Laboratories||ARCHITECT HBSAG REAGENT KIT, CALIBRATORS, CONTROLS, CONFIRMATORY REAGENT KIT, CONFIRMATORY MANUAL DILUENT||September 7, 2006|
|P060012/2007M-0153||Abbott Laboratories||AXSYM CORE 2.0 & AXSYM CORE 2.0 CONTROLS||September 8, 2006|
|P990037(S24)/2007M-0188||Vascular Solutions, Inc.||VASCULAR SOLUTIONS D-STAT FLOWABLE HEMOSTAT||December 22, 2006|
|H060003/2007M-0156||EV3 Neurovascular||ONYX LIQUID EMBOLIC SYSTEM (ONYX HD-500, MODEL 105-8101-500)||April 11, 2007|
|P050046/2007M-0154||Guidant Corp.||ACUITY STEERABLE LEAD MODELS 4554, 4555, & 4556||April 13, 2007|
|P040024(S006)/2007M-0180||Medicis Aesthetics Holdings, Inc.||PERLANE INJECTABLE GEL||May 2, 2007|
|P060011/2007M-0189||Rayner Surgical, Inc.||C-FLEX MODEL 570C INTRAOCULAR LENS (IOL)||May 3, 2007|
|H060001/2007M-0190||Cordis Neurovascular, Inc.||ENTERPRISE VASCULAR RECONSTRUCTION DEVICE AND DELIVERY SYSTEM||May 8, 2007|
|P050004/2007M-0253||Electro Medical Systems (EMS) S.A.||EMS SWISS DOLORCLAST||May 8, 2007|
|P050012(S001)/2007M-0255||Dexcom, Inc.||STS-7 CONTINUOUS GLUCOSE MONITORING SYSTEM||May 31, 2007|
|P060034/2007M-0254||Bio-Rad Laboratories||BIO RAD MONOLISA ANTI-HBC IGM EIA||May 31, 2007|
II. Electronic Access
Persons with access to the Internet may obtain the documents at http://www.fda.gov/cdrh/pmapage.html.Start Signature
Dated: August 30, 2007.
Linda S. Kahan,
Deputy Director, Center for Devices and Radiological Health.
[FR Doc. E7-18034 Filed 9-12-07; 8:45 am]
BILLING CODE 4160-01-S